[an error occurred while processing this directive]|[an error occurred while processing this directive]
放射性脑坏死的新认识与防治
王孝深,胡超苏
200032 上海,复旦大学上海医学院肿瘤学系复旦大学附属肿瘤医院放疗科
Research advances in prevention and treatment of cerebral radiation necrosis
Wang Xiaoshen,Hu Chaosu
Department of Radiation Oncology,Fudan University Shanghai Cancer Center,Department of Oncology,Shanghai Medical College,Fudan University,Shanghai 200032,China
Abstract:Cerebral radiation necrosis (CRN) is a serious complication of radiotherapy for intracranial tumors and skull base tumors. Since there lacked effective therapeutic methods in the past, CRN was once considered to be progressive and irreversible. With the development of histopathology and neuroimaging, the development and progression of CRN is gradually clarified, and new therapeutic methods have been developed. In recent years, the scholars at home and abroad have tried to use bevacizumab (a humanized monoclonal antibody targeting vascular endothelial growth factor), nerve growth factor, and ganglioside in the treatment of CRN and have achieved definite therapeutic effects. In some patients, cerebral necrosis was even repaired and reversed. This article reviews the incidence, pathophysiology, treatment, and prognosis of CRN.
Wang Xiaoshen,Hu Chaosu. Research advances in prevention and treatment of cerebral radiation necrosis[J]. Chinese Journal of Radiation Oncology, 2016, 25(9): 911-916.
[1] Ruben JD,Dally M,Bailey M,et al. Cerebral radiation necrosis:incidence,outcomes,and risk factors with emphasis on radiation parameters and chemotherapy[J].Int J Radiat Oncol Biol Phys,2006,65(2):499-508.DOI:10.1016/j.ijrobp.2005.12.002 [2] Lee AW,Ng SH,Ho JH,et al. Clinical diagnosis of late temporal lobe necrosis following radiation therapy for nasopharyngeal carcinoma[J].Cancer,1988,61(8):1535-1542. [3] Lee AW,Foo W,Chappell R,et al. Effect of time,dose,and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma[J].Int J Radiat Oncol Biol Phys,1998,40(1):35-42. [4] Zhou GQ,Yu XL,Chen M,et al. Radiation-induced temporal lobe injury for nasopharyngeal carcinoma:a comparison of intensity-modulated radiotherapy and conventional two-dimensional radiotherapy[J/OL]. PLoS One,2013,8(7):e67488.DOI:10.1371/journal.pone.0067488. [5] Swinson BM,Friedman WA.Linear accelerator stereotactic radiosurgery for metastatic brain tumors:17 years of experience at the University of Florida[J].Neurosurgery,2008,62(5):1018-1032.DOI:10.1227/01.neu.0000325863.91584.09. [6] Massengale JL,Levy RP,Marcellus M,et al. Outcomes of surgery for resection of regions of symptomatic radiation injury after stereotactic radiosurgery for arteriovenous malformations[J].Neurosurgery,2006,59(3):553-560.DOI:10.1227/01.NEU.0000227476.95859.F1. [7] Belka C,Budach W,Kortmann RD,et al. Radiation induced CNS toxicity:molecular and cellular mechanisms[J].Br J Cancer,2001,85(9):1233-1239.DOI:10.1054/bjoc.2001.2100. [8] Wong CS,Van der Kogel AJ.Mechanisms of radiation injury to the central nervous system:implications for neuroprotection[J].Mol Interv,2004,4(5):273-284.DOI:10.1124/mi.4.5.7. [9] Tofilon PJ,Fike JR.The radioresponse of the central nervous system:a dynamic process[J].Radiat Res,2000,153(4):357-370. [10] Yoshii Y.Pathological review of late cerebral radionecrosis[J]. Brain Tumor Pathol.2008,25(2):51-58.DOI:10.1007/s10014-008-0233-9. [11] Husain MM,Garcia JH.Cerebral “radiation necrosis”:vascular and glial features[J].Acta Neuropathologica,1976,36(4):381-385. [12] Burger PC,Boyko OB.The pathology of central nervous system radiation injury[A]//Gutin PH,Leibel SA,Sheline GE,eds.Radiation injury to the nervous system[M].New York,NY:Raven,1991:191-208. [13] Levin VA,Edwards MS,Byrd A.Quantitative observations of the acute effects of X-irradiation on brain capillary permeability:part I[J].Int J Radiat Oncol Biol Phys,1979,5(9):1627-1631. [14] Adamson IY,Bowden DH,Wyatt JP.A pathway to pulmonary fibrosis:an ultrastructural study of mouse and rat following radiation to the whole body and hemithorax[J].Am J Pathol,1970,58(3):481-498. [15] Kim JH,Chung YG,Kim CY,et al. Up-regulation of VEGF and FGF2 in normal rat brain after experimental intraoperative radiation therapy[J].J Korean Med Sci,2004,19(6):879-886.DOI:10.3346/jkms.2004.19.6.879. [16] Li Y-Q,Ballinger JR,Nordal RA,et al. Hypoxia in radiation induced blood-spinal cord barrier breakdown[J].Cancer Res,2001,61(8):3348-3354. [17] van der Maazen RW,Kleiboer BJ,Verhagen I,et al. Irradiation in vitro discriminates between different O-2A progenitor cell subpopulations in the perinatal central nervous system of rats[J].Radiat Res,1991,128(1):64-72. [18] Castel JC,Caille JM.Imaging of irradiated brain tumours:value of magnetic resonance imaging[J].J Neuroradiol,1989,16(2):81-132. [19] Vrdoljak E,Bill CA,Stephens LC,et al. Radiation-induced apoptosis of oligodendrocytes in vitro[J].Int J Radiat Biol,1992,62(4):475-480. [20] Li YQ,Jay V,Wong CS.Oligodendrocytes in the adult rat spinal cord undergo radiation-induced apoptosis[J].Cancer Res,1996,56(23):5417-5422. [21] Cammer W.Effects of TNF alpha on immature and mature oligodendrocytes and their progenitors in vitro[J].Brain Res,2000,864(2):213-219. [22] Sundgren PC,Cao Y.Brain irradiation:effects on normal brain parenchyma and radiation injury[J].Neuroimag Clin N Am,2009,19(4):657-668.DOI:10.1016/j.nic.2009.08.014. [23] Di Chiro G,Oldfield E,Wright DC,et al. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors:PET and neuropathologic studies[J].AJR Am J Roentgenol,1988,150(1):189-197.DOI:10.2214/ajr.150.1.189. [24] Gobbel GT,Bellinzona M,Vogt AR,et al. Response of postmitotic neurons to X-irradiation:implications for the role of DNA damage in neuronal apoptosis[J]. J Neurosci,1998,18(1):147-155. [25] Bellinzona M,Gobbel GT,Shinohara C,Fike JR.Apoptosis is induced in the subependyma of young adult rats by ionizing irradiation[J].Neurosci Lett,1996,208(3):163-166. [26] Van Eldik LJ,Thompson WL,Ralay Ranaivo H,et al. Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases:function-based and target-based discovery approaches[J].Int Rev Neurobiol,2007,82:277-296.DOI:10.1016/S0074-7742(07)82015-0. [27] Glantz MJ,Burger PC,Friedman AH,et al. Treatment of radiation-induced nervous system injury with heparin and warfarin[J].Neurology,1994,44(11):2020-2027. [28] Gonzalez J,Kumar AJ,Conrad CA,et al. Effect of bevacizumab on radiation necrosis of the brain[J].Int J Radiat Oncol Biol Phys,2007,67(2):323-326.DOI:10.1016/j.ijrobp.2006.10.010. [29] Dvorak HF,Sioussat TM,Brown LF,et al. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors:Concentration in tumor blood vessels[J].J Exper Med,1991,174(5):1275-1278. [30] Senger DR,Galli SJ,Dvorak AM,et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid[J].Science,1983,219(4587):983-985. [31] Wong ET,Huberman M,Lu XQ,et al. Bevacizumab reverses cerebral radiation necrosis[J].J Clin Oncol,2008,26(34):5649-5650.DOI:10.1200/JCO.2008.19.1866. [32] Levin VA,Bidaut L,Hou P,et al. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system[J]. Int J Radiat Oncol Biol Phys,2011,79(5):1487-1495.DOI:10.1016/j.ijrobp.2009.12.061. [33] Wang X,Ying H,Zhou Z,et al. Successful treatment of radiation-induced temporal lobe necrosis with mouse nerve growth factor[J].J Clin Oncol,2011,29(7):166-168.DOI:10.1200/JCO.2010.31.7081. [34] Wang XS,Ying HM,He XY,et al. Treatment of cerebral radiationnecrosis with nerve growth factor:a prospective,andomized,ontrolled phase Ⅱ study[J].Radiother Oncol,2016,May 2.pii:S0167-8140(16)31073-8.DOI:10.1016/j.radonc.2016.04.027. [35] Geisler FH,Dorsey FC,Coleman WP.Recovery of motor function after spinal-cord injury—a randomized,placebo controlled trial with GM-1 ganglioside[J].N Engl J Med,1991,324(26):1829-1838.DOI:10.1056/NEJM199106273242601 [36] Bassi S,Albizzati MG,Sbacchi M,et al. Double-blind evaluation of monosialoganglioside (GM1) therapy in stroke[J].J Neurosci Res, 1984,12(2-3):493-498.DOI:10.1002/jnr.490120232. [37] Jonsson G,Gorio A,Hallman H,et al. Effects of GM1 ganglioside on developing and mature serotonin and noradrenaline neurons lesioned by selective neurotoxins[J].J Neurosci Res,1984,12(2-3):459-475.DOI:10.1002/jnr.490120229. [38] Brustle O,Jones KN,Learish RD,et al. Embryonic stem cell-derived glial precursors:a source of myelinating transplants[J].Science,1999,285(5428):754-756. [39] Groves AK,Barnett SC,Franklin RJ,et al. Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells[J].Nature, 1993,362(6419):453-455.DOI:10.1038/362453a0. [40] Ijichi A,Noel F,Sakuma S,et al. Ex vivo gene delivery of platelet-derived growth factor increases 0-2A progenitors in adult rat spinal cord[J].Gene Ther,1996,3(5):389-395.